Anti-SMAD7 monoclonal antibody

Pre-made anti-SMAD7 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to SMAD7/SMAD7 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T94695-Ab-1/ GM-Tg-hg-T94695-Ab-2Anti-Human SMAD7 monoclonal antibodyHuman
GM-Tg-rg-T94695-Ab-1/ GM-Tg-rg-T94695-Ab-2Anti-Rat SMAD7 monoclonal antibodyRat
GM-Tg-mg-T94695-Ab-1/ GM-Tg-mg-T94695-Ab-2Anti-Mouse SMAD7 monoclonal antibodyMouse
GM-Tg-cynog-T94695-Ab-1/ GM-Tg-cynog-T94695-Ab-2Anti-Cynomolgus/ Rhesus macaque SMAD7 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T94695-Ab-1/ GM-Tg-felg-T94695-Ab-2Anti-Feline SMAD7 monoclonal antibodyFeline
GM-Tg-cang-T94695-Ab-1/ GM-Tg-cang-T94695-Ab-2Anti-Canine SMAD7 monoclonal antibodyCanine
GM-Tg-bovg-T94695-Ab-1/ GM-Tg-bovg-T94695-Ab-2Anti-Bovine SMAD7 monoclonal antibodyBovine
GM-Tg-equg-T94695-Ab-1/ GM-Tg-equg-T94695-Ab-2Anti-Equine SMAD7 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T94695-Ab-1/ GM-Tg-hg-T94695-Ab-2; GM-Tg-rg-T94695-Ab-1/ GM-Tg-rg-T94695-Ab-2;
GM-Tg-mg-T94695-Ab-1/ GM-Tg-mg-T94695-Ab-2; GM-Tg-cynog-T94695-Ab-1/ GM-Tg-cynog-T94695-Ab-2;
GM-Tg-felg-T94695-Ab-1/ GM-Tg-felg-T94695-Ab-2; GM-Tg-cang-T94695-Ab-1/ GM-Tg-cang-T94695-Ab-2;
GM-Tg-bovg-T94695-Ab-1/ GM-Tg-bovg-T94695-Ab-2; GM-Tg-equg-T94695-Ab-1/ GM-Tg-equg-T94695-Ab-2
Products NameAnti-SMAD7 monoclonal antibody
Formatmab
Target NameSMAD7
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody, Cytokine antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-SMAD7 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T94695-Ag-1Recombinant multi-species SMAD7/ CRCS3/ MADH7 protein
    CytokineGM-Tg-g-T94695-Ag-1SMAD family member 7 (SMAD7) protein
    ORF Viral VectorpGMLP001429human SMAD7 Lentivirus plasmid
    ORF Viral VectorvGMLP001429human SMAD7 Lentivirus particle
    ORF Viral VectorpGMAAV000122mouse Smad7 AAV plasmid
    ORF Viral VectorvGMAAV000122mouse Smad7 AAV particle


    Target information

    Target IDGM-T94695
    Target NameSMAD7
    Gene ID4092,17131,81516,698338,490570,101088277,535916,100033853
    Gene Symbol and SynonymsCRCS3,MADH7,MADH8,SMAD7
    Uniprot AccessionO15105,O88406
    Uniprot Entry NameSMAD7_HUMAN,SMAD7_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target, Cytokine Target
    DiseaseCancer
    Gene EnsemblENSG00000101665
    Target ClassificationTumor-associated antigen (TAA)

    The target: SMAD7, gene name: SMAD7, also named as CRCS3, MADH7, MADH8. The protein encoded by this gene is a nuclear protein that binds the E3 ubiquitin ligase SMURF2. Upon binding, this complex translocates to the cytoplasm, where it interacts with TGF-beta receptor type-1 (TGFBR1), leading to the degradation of both the encoded protein and TGFBR1. Expression of this gene is induced by TGFBR1. Variations in this gene are a cause of susceptibility to colorectal cancer type 3 (CRCS3). Several transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jun 2010].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.